GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoVibronix Inc (STU:56R0) » Definitions » Institutional Ownership

NanoVibronix (STU:56R0) Institutional Ownership : 0.97% (As of Jun. 09, 2024)


View and export this data going back to 2021. Start your Free Trial

What is NanoVibronix Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NanoVibronix's institutional ownership is 0.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NanoVibronix's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NanoVibronix's Float Percentage Of Total Shares Outstanding is 95.59%.


NanoVibronix Institutional Ownership Historical Data

The historical data trend for NanoVibronix's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoVibronix Institutional Ownership Chart

NanoVibronix Historical Data

The historical data trend for NanoVibronix can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 2.30 2.28 1.47 1.33 1.33 1.33 1.33 0.97 0.97 0.97

NanoVibronix Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


NanoVibronix (STU:56R0) Business Description

Traded in Other Exchanges
Address
525 Executive Boulevard, Elmsford, New York, NY, USA, 10523
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

NanoVibronix (STU:56R0) Headlines

No Headlines